The pituitary-adrenal responses to exogenous human corticotropin- releasing hormone in preterm, very low birth weight infants

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 797-799

  Ng, P C ^a   Wong, G W K ^c   Lam, C W K ^a   Lee, C H ^c   Wong, M Y ^b   Fok, T F ^c   Wong, W ^c   Chan, D C F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c Prince of Wales Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; HYALINE MEMBRANE DISEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LUNG DYSPLASIA; MALE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; STRESS; VERY LOW BIRTH WEIGHT;

EID: 0031037872     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.3.3832     Document Type: Article

References (14)

1. Crowley P. 1989 Promoting pulmonary maturity. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press; 746-764.
2. Ng PC. 1993 The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child. 68:330-336.
3. Hanna CE, Keith D, Colasurdo MA, et al. 1993 Hypothalamic pituitary adrenal function in the extremely low birth weight infant. J Clin Endocrinol Metab. 76:384-387.
4. Rizvi ZB, Aniol HS, Myers TF, Zeller WP, Fisher SG, Anderson CL. 1992 Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr. 120:961-965.
5. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. 1991 New Ballard score, expanded to include extremely premature infants. J Pediatr. 119:417-423.
6. Goji K. 1989 The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglyaemia. Acta Endocrinol (Copenh). 120:390-394.
7. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. 1992 The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 326:226-230.
8. Riddick L, Chrousos GP, Jeffries S, Pang S. 1994 Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism. Pediatr Res. 36:213-220.
9. Trainer PJ, Faria M, Newell-Price J, et al. 1995 A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab. 80:412-417.
10. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. 1993 Effects of synthetic ovine corticotropin releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology. 113:1121-1131.
11. Gillies GE, Linton EA, Lowry PJ. 1982 Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 299:355-357.
12. Schürmeyer TH, Avgerinos PC, Gold PW. 1984 Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab. 59:1103-1108.
13. Metzger DL, Wright NM, Veldhuis JD, Rogol AD, Kerrigan JR. 1993 Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis. J Clin Endocrinol Metab. 77:458-463.
14. Wand GS, Ney RL. 1985 Disorders of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol Metab. 14:33-53.